MedTrace Logo

A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy.

NCT01753804 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 269

Last updated 2017-12-08

No results posted yet for this study

Summary

To characterize the natural history and progression of Duchenne Muscular Dystrophy (DMD) to help inform the design of future studies, to capture biomarkers of safety and disease progression and to provide comparative data for the development of rare exons for which formal controlled trials are not feasible.

Conditions

Interventions

OTHER

Observational study

There is no medication or device tested in this study. This is an obversational study on the progression of the disease.

Sponsors & Collaborators

Principal Investigators

  • Nathalie Goemans, MD · UZ Leuven, Belgium

Eligibility

Min Age
3 Years
Max Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-01
Primary Completion
2016-10-01
Completion
2016-10-01

Countries

  • United States
  • Argentina
  • Belgium
  • Brazil
  • France
  • Germany
  • Italy
  • Netherlands
  • Sweden
  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01753804 on ClinicalTrials.gov